Jim Cramer lifts up the market hood to figure out what is behind Tuesday's market rally. Hint: It's not earnings...or industrials» Read More
Last month's employment report can be classified in one way: steady as she goes. The data were basically in-line.
Some of Friday's midday movers:
Trading exchange-traded products tied to the VIX has been a popular way of hedging risk but the creator of the VIX has this warning.
Private equity billionaire Wilbur Ross tells CNBC he's more likely to put money to work in Europe, after the ECB's interest rate move.
Investors are already wondering what high-priced stocks will next pierce $700 a share as Apple is on the verge of splitting its share price.
Traders bet big on Apple ahead of the company's split. Will the split create options confusion? With CNBC's Melissa Lee and the Options Action traders.
The stock market is looking to Friday's jobs report as the next big driver.
The traders look at options trades that caught their attention today, with CNBC's Melissa Lee and the Options Action traders. This week,
Some of the names on the move ahead of the open.
Regrets? Those who take Social Security before full retirement age have a few, according to a survey by Nationwide Insurance.
Tenet Healthcare stock is on the verge of a big breakout, Chris Verrone of Strategas Research Partners says.
Mary Jo White spoke of the need for a "comprehensive review" of market structure, including rules adopted a decade ago that helped create high-speed trading.
Cramer can’t help but wonder if Mario Draghi will go down in history as the man who got Europe back on its feet.
Hedge funds that use computer models to invest, like BlueCrest's BlueTrend, have lost assets recently, but there are signs of hope.
CNBC's Bob Pisani speaks to Jeffrey Sprecher, ICE CEO, about the uncertain economy and trading structure at the NYSE.
Check out which companies are making headlines after the bell Thursday: Diamond Foods, Verifone & more.
If CEO Manny Chirico doesn't turn things around this quarter, apparel maker PVH's stock will lose out to rival VF, CNBC's Jim Cramer says.
If you’re looking at retail winners, there’s a good chance you’re looking at either Kate Spade or Michael Kors.
Believe it or not, the bull may not need substantial job growth to survive. In fact, Cramer says it can thrive without it.
For the past several months biotech stocks have fallen out of favor on Wall Street. That may be about to change.
Get the best of CNBC in your inbox